Vancouver-Based mRNA Vaccine Producer Receives $18.2 Million

Vancouver based Precision Nanosystems, Inc. (PNI) announced that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development’s Strategic Innovation Fund to develop a COVID-19 vaccine. PNI stated on October 23, 2020, 'it will use the investment to advance a best-in-class COVID-19 mRNA vaccine candidate to clinical trials.'

The Government of Canada has now signed vaccine supply agreements with Medicago, AstraZeneca, Sanofi and GlaxoSmithKline, Johnson & Johnson, Novavax, Pfizer, and Moderna. Agreements signed to date will secure access to up to 358 million doses of their different COVID-19 vaccine candidates.